文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

评估作为2型糖尿病并发症的溃疡患者中所选金属蛋白酶(MMP-2、MMP-3、MMP-9和MMP-13)的浓度。

Assessment of the concentration of selected metalloproteinases (MMP-2, MMP-3, MMP-9 and MMP-13) in patients with ulcers as a complication of type 2 diabetes.

作者信息

Kupczyk Daria, Bilski Rafał, Studziñska Renata, Woźniak Alina

机构信息

Department of Medical Biology and Biochemistry Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.

Department of Organic Chemistry Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.

出版信息

Postepy Dermatol Alergol. 2022 Feb;39(1):59-65. doi: 10.5114/ada.2020.100737. Epub 2020 Nov 13.


DOI:10.5114/ada.2020.100737
PMID:35369620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953868/
Abstract

INTRODUCTION: Impaired chronic wound healing is a great challenge for modern medicine. This process causes ulceration especially in the course of diseases such as type II diabetes mellitus. AIM: This study assesses the concentration of selected matrix metalloproteinases in the example of metalloproteinase 2, 3, 9, 13 in patients with impaired healing of chronic wounds as a complication of type 2 diabetes. MATERIAL AND METHODS: Nineteen people took part in the assessment of wound healing in patients with type 2 diabetes. The control group consisted of 21 healthy people. In the blood serum the concentration of MMP-2, MMP-3, MMP-9 and MMP-13 was determined. RESULTS: The concentrations of MMP-2 and MMP-3 in the group of patients with ulcers were significantly higher (61% and 84% accordingly) compared to those in the control group without chronic wounds. No statistically significant differences in MMP-9 and MMP-13 concentrations were observed between the study and control groups. CONCLUSIONS: The increase in MMP-2 concentration, which is particularly active in the degradation of type IV collagen, which is the main component of the basal membranes, in patients with type 2 diabetes may impede and delay the healing of chronic wounds and thus contribute to the intensification of vascular complications. In turn, the increase in MMP-3 concentration, which plays a significant role in vascular diseases, in patients with type 2 diabetes may lead to intensification of atherosclerotic changes involving the arteries of the lower extremities and ulceration.

摘要

引言:慢性伤口愈合受损是现代医学面临的巨大挑战。这一过程会导致溃疡,尤其是在II型糖尿病等疾病过程中。 目的:本研究以金属蛋白酶2、3、9、13为例,评估2型糖尿病并发症慢性伤口愈合受损患者中所选基质金属蛋白酶的浓度。 材料与方法:19人参与了2型糖尿病患者伤口愈合情况的评估。对照组由21名健康人组成。测定血清中MMP - 2、MMP - 3、MMP - 9和MMP - 13的浓度。 结果:溃疡患者组中MMP - 2和MMP - 3的浓度显著高于无慢性伤口的对照组(分别为61%和84%)。研究组与对照组在MMP - 9和MMP - 13浓度上未观察到统计学显著差异。 结论:2型糖尿病患者中MMP - 2浓度升高,MMP - 2在基底膜主要成分IV型胶原的降解中特别活跃,可能会阻碍和延迟慢性伤口的愈合,从而导致血管并发症加剧。而2型糖尿病患者中MMP - 3浓度升高,MMP - 3在血管疾病中起重要作用,可能会导致涉及下肢动脉的动脉粥样硬化改变加剧和溃疡形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/d9c649def84e/PDIA-39-42371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/29bf91d7058e/PDIA-39-42371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/462f06cf619d/PDIA-39-42371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/d9c649def84e/PDIA-39-42371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/29bf91d7058e/PDIA-39-42371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/462f06cf619d/PDIA-39-42371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7700/8953868/d9c649def84e/PDIA-39-42371-g003.jpg

相似文献

[1]
Assessment of the concentration of selected metalloproteinases (MMP-2, MMP-3, MMP-9 and MMP-13) in patients with ulcers as a complication of type 2 diabetes.

Postepy Dermatol Alergol. 2022-2

[2]
Uncontrolled gelatin degradation in non-healing chronic wounds.

J Wound Care. 2018-11-2

[3]
Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.

Diabetologia. 2002-7

[4]
Concentration of proinflammatory cytokines in patients with ulcers as a complication of type 2 diabetes mellitus.

Postepy Dermatol Alergol. 2021-10

[5]
Role of matrix metalloproteinases in non-healing venous ulcers.

Int Wound J. 2015-12

[6]
MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.

J Surg Res. 1999-2

[7]
Restructuring of the extracellular matrix in diabetic wounds and healing: A perspective.

Pharmacol Res. 2016-3-24

[8]
Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers.

Wound Repair Regen. 2002

[9]
[Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages Ⅲ and Ⅳ pressure ulcers].

Zhonghua Shao Shang Za Zhi. 2019-10-20

[10]
The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.

Eur J Vasc Endovasc Surg. 2006-3

引用本文的文献

[1]
Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face.

Arch Intern Med Res. 2024

[2]
Multifunctional Casein-Based Wound Dressing Capable of Monitoring and Moderating the Proteolytic Activity of Chronic Wounds.

Biomacromolecules. 2024-2-12

[3]
Targeting matrix metalloproteases in diabetic wound healing.

Front Immunol. 2023

[4]
Serum Level of MMP-3 and MMP-9 in Patients with Diabetes Mellitus Type 2 Infected with Epstein-Barr Virus.

Int J Mol Sci. 2022-11-6

本文引用的文献

[1]
Concentration of proinflammatory cytokines in patients with ulcers as a complication of type 2 diabetes mellitus.

Postepy Dermatol Alergol. 2021-10

[2]
Structure and Function of Human Matrix Metalloproteinases.

Cells. 2020-4-26

[3]
Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.

Iran J Kidney Dis. 2018-1

[4]
Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions.

J Cell Physiol. 2016-12

[5]
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.

J Enzyme Inhib Med Chem. 2016

[6]
The skin remodeling in type 1 diabetes and insulin resistance animal models.

Physiol Res. 2015

[7]
Changes in the prevalence of diabetes mellitus in bulgaria (2006-2012).

Clin Med Insights Endocrinol Diabetes. 2015-5-12

[8]
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.

Cardiovasc Diabetol. 2015-3-10

[9]
Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus.

Acta Diabetol. 2013-5-1

[10]
Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles.

Cerebrovasc Dis. 2011-3-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索